barriers to getting a glp-1 medication prescribed Addressing Access and Adherence Challenges with Specialty Pharmacy Solutions Insights from Specialty Physicians on

That is a 2.5-fold increase in the likelihood of achieving a transformative weight loss outcome

The amyloid hypothesis of Alzheimers disease: Progress and problems on the road to therapeutics

Over the past several years, glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide and tirzepatide have emerged as breakthrough therapies in the fight against obesity and related metabolic disorders

However, there are examples of drugs being withdrawn from the market as more long-term data comes to light

The growing focus on developing oral formulations to improve patient adherence is expected to present several market opportunities

"Healthy fats, like monounsaturated fats and omega-3 fatty acids (such as DHA), can help release more GLP-1